| Phenotypic properties of transmitted founder HIV-1 NF Parrish, F Gao, H Li, EE Giorgi, HJ Barbian, EH Parrish, L Zajic, ... Proceedings of the National Academy of Sciences 110 (17), 6626-6633, 2013 | 481 | 2013 |
| Examination of the contributions of size and avidity to the neutralization mechanisms of the anti-HIV antibodies b12 and 4E10 JS Klein, PNP Gnanapragasam, RP Galimidi, CP Foglesong, AP West Jr, ... Proceedings of the National Academy of Sciences 106 (18), 7385-7390, 2009 | 191 | 2009 |
| Design and characterization of structured protein linkers with differing flexibilities JS Klein, S Jiang, RP Galimidi, JR Keeffe, PJ Bjorkman Protein Engineering, Design & Selection 27 (10), 325-330, 2014 | 165 | 2014 |
| Cryo-EM structure of a CD4-bound open HIV-1 envelope trimer reveals structural rearrangements of the gp120 V1V2 loop H Wang, AA Cohen, RP Galimidi, HB Gristick, GJ Jensen, PJ Bjorkman Proceedings of the National Academy of Sciences 113 (46), E7151-E7158, 2016 | 158 | 2016 |
| Intra-spike crosslinking overcomes antibody evasion by HIV-1 RP Galimidi, JS Klein, MS Politzer, S Bai, MS Seaman, MC Nussenzweig, ... Cell 160 (3), 433-446, 2015 | 128 | 2015 |
| The microRNA-132 and microRNA-212 cluster regulates hematopoietic stem cell maintenance and survival with age by buffering FOXO3 expression A Mehta, JL Zhao, N Sinha, GK Marinov, M Mann, MS Kowalczyk, ... Immunity 42 (6), 1021-1032, 2015 | 98 | 2015 |
| Design and expression of a dimeric form of human immunodeficiency virus type 1 antibody 2G12 with increased neutralization potency AP West Jr, RP Galimidi, CP Foglesong, PNP Gnanapragasam, ... Journal of virology 83 (1), 98-104, 2009 | 60 | 2009 |
| Asymmetric recognition of HIV-1 Envelope trimer by V1V2 loop-targeting antibodies H Wang, HB Gristick, L Scharf, AP West Jr, RP Galimidi, MS Seaman, ... Elife 6, e27389, 2017 | 59 | 2017 |
| Single-chain Fv-based anti-HIV proteins: potential and limitations AP West Jr, RP Galimidi, PNP Gnanapragasam, PJ Bjorkman Journal of virology 86 (1), 195-202, 2012 | 49 | 2012 |
| Evaluation of CD4-CD4i antibody architectures yields potent, broadly cross-reactive anti-human immunodeficiency virus reagents AP West Jr, RP Galimidi, CP Foglesong, PNP Gnanapragasam, JS Klein, ... Journal of virology 84 (1), 261-269, 2010 | 44 | 2010 |
| A dimeric form of the HIV-1 antibody 2G12 elicits potent antibody-dependent cellular cytotoxicity JS Klein, A Webster, PNP Gnanapragasam, RP Galimidi, PJ Bjorkman Aids 24 (11), 1633-1640, 2010 | 40 | 2010 |
| Longitudinal imaging of HIV-1 spread in humanized mice with parallel 3D immunofluorescence and electron tomography C Kieffer, MS Ladinsky, A Ninh, RP Galimidi, PJ Bjorkman elife 6, e23282, 2017 | 30 | 2017 |
| Neutralization properties of simian immunodeficiency viruses infecting chimpanzees and gorillas HJ Barbian, JM Decker, F Bibollet-Ruche, RP Galimidi, AP West Jr, ... MBio 6 (2), 10.1128/mbio. 00296-15, 2015 | 22 | 2015 |
| A link between integral membrane protein expression and simulated integration efficiency SS Marshall, MJM Niesen, A Müller, K Tiemann, SM Saladi, RP Galimidi, ... Cell Reports 16 (8), 2169-2177, 2016 | 21 | 2016 |
| Modular fluorescent nanoparticle DNA probes for detection of peptides and proteins CM Stawicki, TE Rinker, M Burns, SS Tonapi, RP Galimidi, D Anumala, ... Scientific Reports 11 (1), 19921, 2021 | 17 | 2021 |
| Use of mutated self-cleaving 2A peptides as a molecular rheostat to direct simultaneous formation of membrane and secreted anti-HIV immunoglobulins KK Yu, K Aguilar, J Tsai, R Galimidi, P Gnanapragasam, L Yang, ... PLoS One 7 (11), e50438, 2012 | 16 | 2012 |
| Methods of generating nanoarrays and microarrays D Gremyachinskiy, R Galimidi, P Mallick, SM Patel US Patent 11,203,612, 2021 | 11 | 2021 |
| Methods of generating nanoarrays and microarrays D Gremyachinskiy, R Galimidi, P Mallick, SM Patel US Patent App. 17/496,742, 2022 | 3 | 2022 |
| A dimeric form of the HIV-1 antibody 2G12 elicits potent antibody-dependent cellular cytotoxicity: Erratum JS Klein, A Webster, PNP Gnanapragasam, RP Galimidi, PJ Bjorkman Aids 24 (16), 2010 | 1 | 2010 |
| Engineering antigen-specific tolerance to an artificial protein hydrogel PB Rapp, JA Baccile, RP Galimidi, J Vielmetter ACS Biomaterials Science & Engineering 10 (4), 2188-2199, 2024 | | 2024 |
